Overview
Binds to formyl peptide receptors and disrupts pathogen cell membranes.
Proposed mechanism
Cathelicidin-derived antimicrobial peptide disrupting microbial membranes, modulating chemokines, and promoting angiogenesis via FPRL1.
What the evidence supports
Evidence rests primarily on self-reported experience. Controlled studies are lacking.
Graded Anecdotal
Case reports, clinician notes, and user-reported outcomes. Recorded for completeness and labelled plainly so it is never mistaken for data.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
LL-37 antimicrobial activity
· DOI:10.1038/nri2435 · 2008
- [2]
LL-37 antimicrobial activity (2008)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.